On 3/1/24, REGENXBIO Inc (NASDAQ: RGNX) stock enjoyed a major increase of 21.5%, closing at $21.19. Moreover, this advance was accompanied by exceptionally high trading volume at 215% of normal. Relative to the market the stock has been weak over the last nine months but has risen 16.6% during the last week.
Current PriceTarget Research Rating
RGNX’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to be Value Creation neutral.
REGENXBIO has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. REGENXBIO has a poor Power Rating of 25 and a very low Appreciation Score of 8, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment